News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Urologix (ULGX) Announces Pricing of Follow-On Offering of 5,200,000 Shares of Common Stock


6/29/2012 10:02:24 AM

MINNEAPOLIS, June 29, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today announced the pricing of its registered follow-on firm commitment underwritten public offering of 5,200,000 shares of its common stock at a public offering price of $0.75 per share. The public offering is expected to close on or about July 5, 2012, subject to customary closing conditions. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 780,000 shares of its common stock to cover overallotments.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES